[1] Lachman S, Terbraak M S, Limpens J, et al. The prognostic value of heart rate recovery in patients with coronary artery disease A systematic review and meta-analysis[J].Am Heart J,2018,199(1):163-169. [2] Ferrari R, Fox K. Heart rate reduction in coronary artery disease and heart failure[J].Nat Rev Cardiol,2016,13(8):493-501. [3] Gerlach A T, Blais D M, Jones G M, et al. Predictors of dexmedetomidine-associated hypotension in critically ill patients[J].Int J Crit Ill Inj Sci,2016,6(3):109-114. [4] 程海涛, 王礼伟, 陈玲利. 右美托咪定联合生脉注射液对中老年冠心病患者非心脏手术围术期心肌保护效应及对氧化应激、炎性反应的影响[J].现代中西医结合杂志, 2018, 27(20):2256-2259. [5] 杜守峰, 师文华, 孙君隽. 冠心病冠状动脉搭桥术联合右美托咪定靶控输注对冠心病疗效及HR、MAP、RPP的影响[J].中西医结合心脑血管病杂志, 2017, 15(18):2290-2293. [6] 张继如, 陈敏, 王志强, 等. 右美托咪定和七氟醚改善冠心病非心脏手术患者围术期心肌缺血的比较[J].临床麻醉学杂志, 2017, 33(3):273-276. [7] 周章, 阮云丹, 宋俊,等. 全麻与硬膜外麻醉应用于老年冠心病患者肺叶切除手术的比较[J].临床肺科杂志, 2017, 22(8):1460-1462. [8] 徐巧敏, 吴玮凌, 章玲宾,等. 右美托咪定对高脂血症冠心病患者腹腔镜手术围术期血小板活化的影响[J].中国临床药理学与治疗学, 2017, 22(11):1269-1273.
2020, Vol. 37 
